Author:
Cheema Huzaifa Ahmad,Shafiee Arman,Teymouri Athar Mohammad Mobin,Rafiei Mohammad Ali,Shahid Abia,Awan Rehmat Ullah,Khan Minhas Abdul Mannan,Ahmad Mohsin,Nashwan Abdulqadir J.,Fudim Marat
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference11 articles.
1. Hyperkalemia: a review;Evans;J Intensive Care Med.,2005
2. Hyperkalemia with RAAS inhibition: mechanism, clinical significance, and management;Hundemer;Pharmacol Res.,2021
3. Clinical management of hyperkalemia;Palmer;Mayo Clinic Proc.,2021
4. Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia;Li;J Cardiovasc Pharmacol Ther.,2016
5. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial;Agarwal;The Lancet,2019